RomeroV., AkpinarH., AssimosD.G.. Kidney stones: a global picture of prevalence, incidence, and associated risk factors.Rev Urol2010; 12: e86–e96.
2.
LieskeJ.C., Peña de la VegaL.S., SlezakJ.M.. Renal stone epidemiology in Rochester, Minnesota: an update.Kidney Int2006; 69: 760–4.
3.
UribarriJ., OhM.S., CarrollH.J.. The first kidney stone.Ann Intern Med1989; 111: 1006–09.
4.
FinkH.A., WiltT.J., EidmanK.E., GarimellaP.S.. Medical Management to prevent Nephrolithiasis in Adults: A systematic Review for an American College of Physicians Clinical Guidelines.Ann Intern Med2013; 158: 535–43.
5.
HerrelL., PattarasJ., SolomonT., OganK.. Urinary stone risk and cola consumption.Urology2012; 80(5): 990–4.
6.
WolfgramD.F., GunduV., AstorB.C., JhagrooR.A.. Hydrochlorothiazide compared to chlorthalidone in reduction of urinary calcium in patients with kidney stones.Urolithiasis2013; 41(4): 315–22.
7.
GoldfarbD.S., MacDonaldP.A., GunawardhanaL., ChefoS.. Randomized controlled trial of febuxostat versus allopurinol or placebo in individuals with higher urinary uric acid excretion and calcium stones.Clin J Am Soc Nephrol2013; 8(11): 1960–7.
8.
NooriN., HonarkarE., GoldfarbD.S.. Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets.Am J Kidney Dis2014; 63(3): 456–63.
